Safeguarding patient welfare: Who's in charge?

被引：8

作者：

Henney, Jane E. ^{[1
]}

机构：

[1] Univ Cincinnati, Acad Hlth Ctr, Cincinnati, OH 45267 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2006年 / 145卷 / 04期

关键词：

D O I：

10.7326/0003-4819-145-4-200608150-00013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：305 / 307

页数：3

共 9 条

[1]

[Anonymous], 1997, FED REG, V62, P64074

[2]

[Anonymous], 2002, FED REG, V67, P34942

[3] New federal guidelines for physician-pharmaceutical industry relations: The politics of policy formation [J].

Chimonas, S ;

Rothman, DJ .

HEALTH AFFAIRS, 2005, 24 (04) :949-960

[4] Guidelines for interactions between clinical faculty and the pharmaceutical industry: One medical school's approach [J].

Coleman, DL ;

Kazdin, AE ;

Miller, LA ;

Morrow, JS ;

Udelsman, R .

ACADEMIC MEDICINE, 2006, 81 (02) :154-160

[5]

*PHARM RES MAN AM, 2004, PHRAMA COD INT HEALT

[6]

RALDEY DC, 2006, ARCH INTERN MED, V166, P1021

[7] Narrative review: The promotion of gabapentin: An analysis of internal industry documents [J].

Steinman, Michael A. ;

Bero, Lisa A. ;

Chren, Mary-Margaret ;

Landefeld, C. Seth .

ANNALS OF INTERNAL MEDICINE, 2006, 145 (04) :284-293

[8]

1996, FED REG, V61, P52800

[9]

2003, FED REG, V68, P23731

← 1 →